Envista Holdings Corp. (NYSE: NVST) reported Q4 EPS of $0.52, $0.03 better than the analyst estimate of $0.49. Revenue for the quarter came in at $721 million versus the consensus estimate of $729.35 million.

Mr. Aghdaei continued, "Since becoming a fully independent company, we have been able to add to our portfolio through our first acquisition, a dental biomaterials manufacturer, as well as strategic partnerships in intra-oral scanning. We are energized about the opportunity ahead and confident in our ability to drive improved business performance in 2020 and beyond."

GUIDANCE:

Envista Holdings Corp. sees FY2020 EPS of $1.63-$1.73, versus the consensus of $1.72.

For earnings history and earnings-related data on Envista Holdings Corp. (NVST) click here.